Lasa Supergenerics (NSE:LASA) Accounts Payable: ₹21.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LASA Lasa Supergenerics Ltd NSE:LASA
43 GF Score
Price ₹7.11
GF Value ₹4.30
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Lasa Supergenerics Accounts Payable?

Lasa Supergenerics NSE:LASA -2.60% 43 Accounts Payable is ₹21.2 Mil as of Mar. 2026. GuruFocus rates NSE:LASA with a GF Score™ of 43/100 and a GF Value™ of ₹4.30 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Lasa Supergenerics's Accounts Payable for the quarter that ended in Mar. 2026 was ₹21.2 Mil.

Lasa Supergenerics's quarterly Accounts Payable declined from Sep. 2025 (₹45.1 Mil) to Dec. 2025 (₹0.0 Mil) but then increased from Dec. 2025 (₹0.0 Mil) to Mar. 2026 (₹21.2 Mil).

Lasa Supergenerics's annual Accounts Payable declined from Mar. 2024 (₹140.5 Mil) to Mar. 2025 (₹102.2 Mil) and declined from Mar. 2025 (₹102.2 Mil) to Mar. 2026 (₹21.2 Mil).

Lasa Supergenerics Accounts Payable Related Terms

Lasa Supergenerics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Lasa Supergenerics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lasa Supergenerics Accounts Payable Chart

Lasa Supergenerics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 169.10 94.27 140.54 102.18 21.23

Lasa Supergenerics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102.18 0.00 45.14 0.00 21.23
NSE:LASA
43GF Score
Lasa Supergenerics Ltd NSE:LASA
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lasa Supergenerics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹21.2 Mil mean?
Lasa Supergenerics (NSE:LASA) has a Accounts Payable of ₹21.2 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Lasa Supergenerics and its competitors.
Is Lasa Supergenerics' Accounts Payable too high?
Lasa Supergenerics' current Accounts Payable is ₹21.2 Mil. Overall, Lasa Supergenerics has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lasa Supergenerics' Accounts Payable compare to ZTS and UTHR?
Lasa Supergenerics' Accounts Payable of ₹21.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Lasa Supergenerics and its competitors. Lasa Supergenerics's current Accounts Payable is ₹21.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lasa Supergenerics stock overvalued right now?
Based on GuruFocus' analysis, Lasa Supergenerics (NSE:LASA) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹4.30, compared to a current price of ₹7.11 — trading 65.3% above its estimated fair value. The current Accounts Payable is ₹21.2 Mil. Lasa Supergenerics' overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Lasa Supergenerics (NSE:LASA), the current Accounts Payable is ₹21.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lasa Supergenerics (NSE:LASA) Overvalued in 2026?

Based on GuruFocus' analysis, Lasa Supergenerics stock appears to be overvalued. The current stock price of ₹7.11 is trading 65.3% above its estimated GF Value™ of ₹4.30. GuruFocus considers Lasa Supergenerics to be Significantly Overvalued.

Key valuation signals for NSE:LASA:

  • Accounts Payable: ₹21.2 Mil
  • GF Value™: ₹4.30 vs. price of ₹7.11 (65.3% above fair value)
  • GF Score™: 43/100 with 6 warning signs

No single metric tells the full story. See the NSE:LASA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lasa Supergenerics Business Description

Other Exchanges 540702:India
Address Plot No C-4, C-4/1, MIDC, Lote Parshuram Industrial Area, Khed Taluka, Ratnagiri, MH, IND, 415722
Lasa Supergenerics Ltd is engaged in the research, manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharmaceuticals, drugs, and related products. The company specializes in catalyst chemistry and manufactures anthelmintic and veterinary API products. Its product range includes API products, other API products, animal feed ingredients, and reagents for therapeutic use.
43GF Score

Get the complete analysis for NSE:LASA

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹7.11
Price
₹4.30
GF Value